Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORP: Colchicine for Recurrent Pericarditis
NCT00128414Phase 3Completed
- Sponsor
- ASL TO3
- Start
- Aug 2005
- Primary completion
- Apr 2009
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in recurrent pericarditis comparing Colchicine with Placebo (2 arms). Primary endpoint: Recurrence rate at 18 months. Started Aug 2005; status: completed.
02
Drugs
colchicine
03
Conditions
recurrent pericarditis
Beyond the preview
Go deeper on NCT00128414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128414.